isr$case$i_f_cod$foll_seq$image$event_dt$mfr_dt$fda_dt$rept_cod$mfr_num$mfr_sndr$age$age_cod$gndr_cod$e_sub$wt$wt_cod$rept_dt$occp_cod$death_dt$to_mfr$confid$v23
4263764$4060920$I$$4263764-6$20020101$20031219$20040102$EXP$USA031255171$ELI LILLY AND COMPANY$68$YR$F$N$82$KG$20031223$$$$$
4263927$4064250$I$$4263927-X$$20031209$20040102$EXP$B0317710A$GLAXOSMITHKLINE GLOBAL CLINICAL SAFETY$58$YR$F$N$$$20031219$$$$$
4264001$4062524$I$$4264001-9$20031218$20031219$20040102$EXP$JP-JNJFOC-20031204393$CENTOCOR, INC.$53$YR$F$N$36.8$KG$20031231$MD$$$$
4264319$4064506$I$$4264319-X$20031216$20031218$20040105$EXP$MEDI-0001221$MEDIMUNE, INC.$$$F$N$$$20031231$MD$$$$
4266745$4056689$I$$4266745-1$20030529$20040105$20040108$EXP$FR-GLAXOSMITHKLINE-B0318977A$GLAXOSMITHKLINE$48$YR$F$Y$$$20040108$CN$$$$
4268568$4059382$I$$4268568-6$$20040107$20040112$EXP$PHBS2004JP00548$NOVARTIS PHARMACEUTICALS CORP.$$$M$Y$$$20040109$MD$$$$
4268586$3994383$F$$4268586-8$20030826$20030904$20040112$EXP$US-GLAXOSMITHKLINE-A0424697A$GLAXOSMITHKLINE$13$YR$F$Y$$$20040112$CN$$$$
4269553$4061181$I$$4269553-0$20040105$20040106$20040113$EXP$US-BRISTOL-MYERS SQUIBB COMPANY-12471421$BRISTOL-MYERS SQUIBB COMPANY$10$DEC$F$Y$$$20040113$OT$$$$
4269590$4062932$I$$4269590-6$20030602$$20040112$DIR$$$57$YR$M$N$$$$PH$$N$Y$
4269894$4068631$I$$4269894-7$20030805$$20040112$DIR$$$90$YR$M$N$$$$$$N$Y$
4270064$4062312$I$$4270064-7$$20030204$20040114$PER$US-GLAXOSMITHKLINE-A0395406A$GLAXOSMITHKLINE$$$$Y$$$20040114$CN$$$$
4271501$4007339$F$1$4271501-4$20020729$20040106$20040113$EXP$TPA2003A01222$TAKEDA PHARMACEUTICALS NORTH AMERICA.$71$YR$M$N$160$LBS$20040112$MD$$$$
4272687$4072288$I$$4272687-8$20031220$20040109$20040115$EXP$04-01-0044$IVAX PHARMACEUTICALS, INC.$71$YR$F$N$$$20040109$OT$$$$
4274829$4073121$I$$4274829-7$$20031231$20040115$EXP$USA040155657$ELI LILLY AND COMPANY$79$YR$F$N$$$20040107$$$$$
4276604$4019165$F$2$4276604-6$$20040108$20040120$EXP$US-SHR-03-015202$BERLEX LABORATORIES$$$F$N$79.4$KG$20040116$CN$$$$
4276994$4062516$F$2$4276994-4$20031101$20040105$20040120$EXP$03P-062-0245595-00$PPD PHARMACOVIGILANCE$$$F$N$$$20040105$MD$$$$
4277521$4027660$F$1$4277521-8$$20040105$20040121$EXP$DSA_23477_2003$BIOVAIL PHARMACEUTICALS INC.$61$YR$M$N$204$LBS$20040120$MD$$$$
4279336$4022360$F$1$4279336-3$20030911$20040112$20040122$EXP$FR-JNJFOC-20030905591$CENTOCOR, INC.$31$YR$F$N$$$20040121$MD$$$$
4280316$4049927$F$1$4280316-2$20030617$20040115$20040126$EXP$UK059122$AMGEN$65$YR$F$N$63$KG$20040123$$$$$
4280654$4081346$I$$4280654-3$20040112$20040119$20040123$EXP$200410213GDS$BAYER PHARMACEUTICALS CORPORATION$17$YR$F$N$$$20040122$MD$$$$
4281199$4093363$I$$4281199-7$$20030911$20040108$PER$HQWYE745017SEP03$WYETH LABS (RA)$$$F$N$$$20031223$$$$$
4281267$4074460$I$$4281267-X$20031111$20031201$20040123$PER$DL2003219$DANCO LABORATORIES, LLC$$$F$N$$$20031229$OT$$$$
4283791$4091687$I$$4283791-2$$20030415$20040115$PER$NSADSS2003017923$JOHNSON + JOHNSON PHARMACEUTICAL$85$YR$F$N$$$20040108$OT$$$$
4283960$4008465$F$$4283960-1$20010717$20031002$20040202$EXP$WAES 0310USA00338$MERCK HUMAN HEALTH DIVISION$55$YR$M$Y$$$20040203$MD$$$$
4284513$4084187$I$$4284513-1$20030101$$20040130$DIR$$$73$YR$M$N$$$20030124$OT$$Y$N$
4284876$4086360$I$$4284876-7$$20040119$20040202$EXP$A001-002-005955$EISAI INC.$$$F$N$$$20040123$MD$$$$
4285379$4078728$F$1$4285379-6$20030813$20040121$20040202$EXP$2004194398JP$PFIZER INC.$72$YR$F$N$52$KG$20040130$MD$$$$
4286029$4087281$I$$4286029-5$$20040122$20040203$EXP$2004004976$WWS PFIZER PHARMACEUTICALS$$$M$N$$$20040202$CN$$$$
4286712$4072824$F$1$4286712-1$20031209$20040126$20040204$EXP$2004193432JP$PFIZER INC.$53$YR$M$N$$$20040202$OT$$$$
4286757$4081521$F$$4286757-1$20031214$20040127$20040206$EXP$IT-GLAXOSMITHKLINE-B0321668A$GLAXOSMITHKLINE$17$YR$F$Y$$$20040206$CN$$$$
4286940$4088359$I$$4286940-5$20030121$20040129$20040205$EXP$USA-2004-0012715$PURDUE PHARMA L.P.$38$YR$F$N$$$20040204$OT$$$$
4287019$4088362$I$$4287019-9$20040121$20040121$20040205$EXP$US_0401100140$ELI LILLY AND COMPANY$$$F$N$$$20040128$$$$$
4289563$4091829$I$$4289563-7$20030901$20031020$20040126$PER$USA030948470$ELI LILLY AND COMPANY$79$YR$F$N$$$20031208$MD$$$$
4290441$4031969$F$$4290441-8$20030915$20031117$20040210$EXP$WAES 0311USA02022$MERCK HUMAN HEALTH DIVISION$47$YR$F$Y$$$20040211$MD$$$$
4290950$4085061$I$$4290950-1$20021201$20031017$20040211$PER$US-GLAXOSMITHKLINE-A0430692A$GLAXOSMITHKLINE$43$YR$F$Y$$$20040205$CN$$$$
4291212$4085297$I$$4291212-9$$20031113$20040211$PER$US-GLAXOSMITHKLINE-A0439680A$GLAXOSMITHKLINE$$$M$Y$$$20040205$CN$$$$
4291571$4085548$I$$4291571-7$$20030929$20040211$PER$US-GLAXOSMITHKLINE-A0427894A$GLAXOSMITHKLINE$$YR$M$Y$$$20040211$CN$$$$
4291654$4085600$I$$4291654-1$$20031205$20040211$PER$US-GLAXOSMITHKLINE-A0442181A$GLAXOSMITHKLINE$$$F$Y$$$20040211$CN$$$$
4292881$4086526$I$$4292881-X$20030715$20030718$20040212$PER$US-GLAXOSMITHKLINE-A0417260A$GLAXOSMITHKLINE$43$YR$F$Y$$$20040205$CN$$$$
4293613$4094705$I$$4293613-1$20031001$20031014$20040126$PER$USA031049832$ELI LILLY AND COMPANY$71$YR$F$N$68$KG$20031208$$$$$
4293737$4094952$I$$4293737-9$20030801$20031017$20040126$PER$USA031050251$ELI LILLY AND COMPANY$79$YR$M$N$59$KG$20031208$$$$$
4294153$4069438$F$$4294153-6$$20040113$20040213$EXP$PHFR2004GB00577$NOVARTIS PHARMACEUTICALS CORP.$32$YR$F$Y$$$20040212$CN$$$$
4294372$4057044$F$$4294372-9$20031113$20031229$20040211$EXP$JP-BRISTOL-MYERS SQUIBB COMPANY-12468112$BRISTOL-MYERS SQUIBB COMPANY$49$YR$F$Y$$$20040211$OT$$$$
4294513$4092827$I$$4294513-3$$20040123$20040211$EXP$JP_040102562$ELI LILLY AND COMPANY$31$YR$F$N$$$20040204$MD$$$$
4295353$4088611$F$$4295353-1$$20030624$20040216$PER$US-GLAXOSMITHKLINE-A0413750A$GLAXOSMITHKLINE$28$YR$M$Y$$$20040211$MD$$$$
4297303$4088373$F$$4297303-0$20030106$20040203$20040218$EXP$200410247JP$AVENTIS PHARMACEUTICALS, INC.$81$YR$F$Y$$$20040218$MD$$$$
4297385$4086488$F$1$4297385-6$20030901$20040130$20040213$EXP$204243$GENENTECH, INC.$12$YR$M$N$$$20040210$MD$$$$
4298644$4086990$I$$4298644-3$20030626$20030701$20040218$PER$US-GLAXOSMITHKLINE-A0414614A$GLAXOSMITHKLINE$51$YR$F$Y$$$20040206$CN$$$$
4299109$4096835$I$$4299109-5$$20040204$20040217$EXP$2004008292$PFIZER PHARMACEUTICALS$$$$N$$$20040213$MD$$$$
4300112$4098012$I$$4300112-7$$20040205$20040218$EXP$CA-SHR-04-021019$BERLEX LABORATORIES$$$F$N$$$20040217$$$$$
4300793$4069921$F$1$4300793-8$20020101$20031201$20040218$PER$2003-09-0835$SCHERING-PLOUGH CORPORATION$63$YR$F$N$175$LBS$20031201$CN$$$$
4301549$4097709$I$$4301549-2$20030919$20040202$20040219$EXP$7384$MAYNE PHARMA PTY LTD.$58$YR$M$N$$$20040217$$$$$
4303198$4101062$I$$4303198-9$$20030926$20040126$PER$USA030948417$ELI LILLY AND COMPANY$7$YR$M$N$25$KG$20040105$$$$$
4303368$4070719$F$2$4303368-X$20030104$20040212$20040223$EXP$04P-062-0246399-00$PPD PHARMACOVIGILANCE$41$YR$M$N$75$KG$20040212$MD$$$$
4304042$4094841$I$$4304042-6$20040103$20040114$20040223$PER$PHEH2004US00855$NOVARTIS PHARMACEUTICALS CORP.$46$YR$F$N$$$20040130$CN$$$$
4304072$4094862$I$$4304072-4$$20040105$20040223$PER$PHEH2004US00527$NOVARTIS PHARMACEUTICALS CORP.$$$F$N$$$20040130$CN$$$$
4304923$4095558$I$$4304923-3$20031210$20040113$20040226$PER$US-GLAXOSMITHKLINE-A0493116A$GLAXOSMITHKLINE$43$YR$F$Y$$$20040226$CN$$$$
4305272$4095870$F$$4305272-X$20030116$20030122$20040226$PER$US-BRISTOL-MYERS SQUIBB COMPANY-12164810$BRISTOL-MYERS SQUIBB COMPANY$47$YR$F$Y$64$KG$20040226$OT$$$$
4306018$4101782$I$$4306018-1$20040202$20040210$20040225$EXP$USA040258568$ELI LILLY AND COMPANY$78$YR$M$N$110$KG$20040218$MD$$$$
4307962$4098750$I$$4307962-1$$20030206$20040301$PER$US-BRISTOL-MYERS SQUIBB COMPANY-12177598$BRISTOL-MYERS SQUIBB COMPANY$62$YR$M$Y$77$KG$20040227$OT$$$$
4309138$4099613$F$$4309138-0$$20040220$20040302$EXP$US-GLAXOSMITHKLINE-A0499994A$GLAXOSMITHKLINE$$$F$Y$$$20040302$LW$$$$
4309390$4099776$I$$4309390-1$20030801$20040227$20040302$EXP$DE-ROCHE-360096$ROCHE$$$M$Y$$$20040302$MD$$$$
4309892$4100060$I$$4309892-8$20031201$20040116$20040303$PER$US-BRISTOL-MYERS SQUIBB COMPANY-12480174$BRISTOL-MYERS SQUIBB COMPANY$38$YR$M$Y$$$20040226$OT$$$$
4310442$4110850$I$$4310442-0$$20031113$20040301$PER$WAES 0311USA01474$MERCK + CO., INC.$56$YR$F$N$$$20040224$MD$$$$
4310686$4112090$I$$4310686-8$$20031210$20040301$PER$WAES 0312USA01447$MERCK + CO., INC.$$$F$N$$$20040224$OT$$$$
4310779$4100504$I$$4310779-5$20031201$20040223$20040303$EXP$WAES 0402USA01743$MERCK HUMAN HEALTH DIVISION$54$YR$F$Y$47$KG$20040304$MD$$$$
4310862$4105049$I$$4310862-4$20040211$20040217$20040302$EXP$2004200062JP$PFIZER INC.$37$YR$F$N$$$20040227$MD$$$$
4312635$4101755$I$$4312635-5$20040214$20040301$20040305$EXP$WAES 0403ITA00001$MERCK HUMAN HEALTH DIVISION$92$YR$F$Y$$$20040308$OT$$$$
4314135$4105619$I$$4314135-5$$$20040308$DIR$$$$$M$N$173$LBS$20040307$CN$$N$N$
4314728$4103666$I$$4314728-5$20040101$20040303$20040310$EXP$ES-BRISTOL-MYERS SQUIBB COMPANY-12522983$BRISTOL-MYERS SQUIBB COMPANY$48$YR$M$Y$$$20040310$OT$$$$
4316846$4109649$I$$4316846-4$20040201$20040302$20040311$EXP$US-JNJFOC-20040300828$JOHNSON + JOHNSON PHARMACEUTICAL$60$YR$M$N$$$20040309$MD$$$$
4316948$4110106$I$$4316948-2$20040223$20040225$20040312$EXP$205112$GENENTECH, INC.$56$YR$F$N$88$KG$20040310$MD$$$$
4317126$4110282$I$$4317126-3$20011005$20040308$20040312$EXP$STA-AE-04-MTX-094$CLONMEL HEALTHCARE LDT$60$YR$F$N$$$20040308$$$$$
4317723$4107940$I$$4317723-5$$20040303$20040315$EXP$PHEH2004US02942$NOVARTIS PHARMACEUTICALS CORP.$$$$Y$$$20040312$MD$$$$
4318270$4109413$I$$4318270-7$$20040128$20040315$PER$2004196709US$PFIZER INC.$$$$N$$$20040301$CN$$$$
4318479$4112153$I$$4318479-2$20040301$$20040317$DIR$$$63$YR$F$N$75.9$KG$20040316$OT$$Y$N$
4318770$4108929$F$$4318770-X$$20031126$20040318$EXP$US-GLAXOSMITHKLINE-A0441716A$GLAXOSMITHKLINE$$$F$Y$$$20040318$CN$$$$
4319252$4110785$I$$4319252-1$20040315$$20040318$DIR$$$60$YR$F$N$$$20040316$MD$$Y$Y$
4322216$4083898$F$1$4322216-5$20030901$20040305$20040319$EXP$2004004001$PFIZER INC$54$YR$M$N$170$LBS$20040317$$$$$
4322271$4114875$I$$4322271-2$20031202$20040312$20040319$EXP$163-20785-04020521 (0)$CELGENE CORPORATION WWDSS$78$YR$M$N$$$20040312$MD$$$$
4322418$4114995$I$$4322418-8$20040201$20040309$20040319$EXP$2004016405$WWS PFIZER INC$45$YR$F$N$60$KG$20040317$MD$$$$
4322977$4115546$I$$4322977-5$20040201$20040315$20040322$EXP$2004-00980$WATSON LABORATORIES, INC.$$$F$N$$$20040317$MD$$$$
4324022$4114021$I$$4324022-4$$20031209$20040326$PER$US-GLAXOSMITHKLINE-A0442548A$GLAXOSMITHKLINE$$YR$M$Y$$$20040326$CN$$$$
4324041$4114039$F$$4324041-8$$20031210$20040326$PER$US-GLAXOSMITHKLINE-A0442767A$GLAXOSMITHKLINE$$$F$Y$$$20040326$CN$$$$
4324746$4065553$F$$4324746-9$20000829$20030609$20040326$EXP$WAES 0306USA01131$MERCK HUMAN HEALTH DIVISION$43$YR$F$Y$65$KG$20040326$MD$$$$
4325623$4117370$I$$4325623-X$$20040308$20040324$EXP$US97082101A$ELI LILLY AND COMPANY$37$YR$F$N$82$KG$20040317$$$$$
4326344$4117966$I$$4326344-X$20040325$$20040329$DIR$$$43$YR$M$N$93$KG$20040327$PH$$N$Y$
4327943$4119462$F$1$4327943-1$20040206$20040310$20040325$EXP$JPT 2004 0001 FUP$GUERBET LLC$77$YR$M$N$$$20040318$MD$$$$
4328323$4123148$I$$4328323-5$20031216$20031222$20040325$PER$KII-2003-0006905$PURDUE PHARMACEUTICAL PRODUCTS L.P.$79$YR$F$N$$$20040322$OT$$$$
4330031$4120467$I$$4330031-1$20040310$20040318$20040329$EXP$2004SE01561$ASTRAZENECA PHARMACEUTICALS$43$YR$M$N$70$KG$20040325$$$$$
4330060$4120654$I$$4330060-8$$20040113$20040319$PER$US-JNJFOC-20040102330$JOHNSON + JOHNSON PHARMACEUTICAL$$$F$N$$$20040311$CN$$$$
4331457$4122073$I$$4331457-2$20020101$20040323$20040329$EXP$2004-03-1625$SCHERING-PLOUGH CORPORATION$$$M$N$$$20040323$CN$$$$
4334007$4122113$I$$4334007-X$20031230$20040115$20040329$PER$04P-163-0247233-00$PPD PHARMACOVIGILANCE$$$F$N$$$20040115$$$$$
4338901$4126596$I$$4338901-5$20040206$20040209$20040329$PER$04P-163-0249704-00$PPD PHARMACOVIGILANCE$$$F$N$$$20040209$$$$$
4346258$4103263$I$$4346258-9$20030901$20031222$20040325$PER$USA030947546$ELI LILLY AND COMPANY$74$YR$F$N$$$20040309$$$$$
4346899$4135105$I$$4346899-9$20030101$20031222$20040329$PER$USA031255274$ELI LILLY AND COMPANY$6$YR$M$N$27$KG$20040301$$$$$
4347265$4133168$I$$4347265-2$20040128$20040217$20040325$PER$USA040158011$ELI LILLY AND COMPANY$76$YR$F$N$$$20040309$$$$$
4373559$4151463$F$1$4373559-0$20030923$20031209$20040305$PER$2003UW14133$ASTRAZENECA PHARMACEUTICALS$78$YR$M$N$243$LBS$20040223$MD$$$$
4373586$4111031$I$$4373586-3$20040123$20040123$20040305$PER$2004UW01678$ASTRAZENECA PHARMACEUTICALS$56$YR$M$N$$$20040223$MD$$$$
4373706$4151560$I$$4373706-0$$20040106$20040305$PER$2004UW00207$ASTRAZENECA PHARMACEUTICALS$$$$N$$$20040223$$$$$
